Skip to Main Content

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Dubai Health Authority - هيئة الصحة دبي

Text Resize

Use the buttons below to increase or decrease the text size

Contrast switch

Use the toggle below to switch the contrast.

SCREEN READER

Listen to the content of the page by clicking play on ReadSpeaker.

Access

To discover more about accessibility, view our Accessibility Options here

Circular No. 2461 for the year 2024

1 Apr 2024

Reference: CIR-2024-00000060


To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Circular No. 2461 for the year 2024 regarding the Addition of warning (Paralyzing Agent) to all registered packages of the therapeutic group Neuromuscular blocking Agents (All neuromuscular blocking products (NMB))

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

icon

All neuromusclar blocking products -NMB ++.pdf

icondownload

Do you find this Content helpful?

Close
Phone